№ files_lp_4_process_3_096827
File format: docx Character count: 492 File size: 16 KB
Randomized clinical trial report presenting the effects of aspirin and tranexamic acid in patients undergoing coronary artery surgery.
Year: 2007
Trial Registration: EudraCT 2007-003666-17
Local R&I Number: CS/2007/2608
Journal: The New England Journal of Medicine
Publication Date: Feb 25, 2016
Authors: Paul S Myles, Julian A Smith, Andrew Forbes, Brendan Silbert, Mohandas Jayarajah, Thomas Painter, D James Cooper, Silvana Marasco, John McNeil, Jean S Bussieres, S Wallace
Research Network: ANZCA Clinical Trials Network
Study Type: Clinical trial
Medical Field: Cardiac surgery / Pharmacology
Interventions: Aspirin, Tranexamic Acid
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.

The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Treatment Of Stroke reCurrence in CAA with TraneXamic Acid
Year: 2024
Region / city: Australia
Topic: Medical Research, Stroke, Cerebral Amyloid Angiopathy, Clinical Trial
Document Type: Participant Information Sheet / Consent Form
Organization / institution: Alfred Health
Author: Dr. Oshi Swarup, Prof Geoffrey Cloud, Prof Nawaf Yassi
Target Audience: Adults with Cerebral Amyloid Angiopathy
Period of Action: 26 weeks
Approval Date: Not specified
Date of Changes: Not specified
Patient Group Direction (PGD) Administration of Tranexamic Acid Injection by Registered Paramedics, Nurses and Midwives for Treatment of Severe Haemorrhage
Year: 2025
Region / City: UK
Topic: Healthcare, Medication Guidelines
Document Type: Medical Protocol
Organisation: National Ambulance Service Medical Directors (NASMeD)
Author: Dr. Elizabeth Miller, Dr. Dave Macklin, Mr. Andy Curran, Rosie England, Cathryn James, Dan Haworth, Tracy Rogers, Jo Jenkins, Rosie Furner
Target Audience: Registered healthcare professionals, Paramedics, Nurses, Midwives
Effective Date: May 2023
Review Date: October 2025
Expiry Date: April 2026
Approval Date: May 2025
Change History: Includes updates to drug administration protocols and clinical guidelines
Post-partum haemorrhage and tranexamic acid: a global issue
Year: 2016
Region / city: Global
Topic: Maternal health, Post-partum haemorrhage
Document type: Research review
Organization / institution: British Journal of Haematology, St Bartholomew’s Hospital, London School of Hygiene and Tropical Medicine
Author: Stephen P Hibbs, Ian Roberts, Haleema Shakur-Still, Beverley J Hunt
Target audience: Healthcare professionals, researchers, policymakers
Period of validity: Ongoing
Approval date: Not specified
Date of revisions: Not specified
ISMP Updates High-Alert Medication List Changes Include Addition of Tranexamic Acid Injection
Year: 2024
Region / City: Plymouth Meeting, Pa.
Topic: Medication Safety
Document Type: Press Release
Organization / Institution: Institute for Safe Medication Practices (ISMP)
Author: Renee Brehio
Target Audience: Healthcare professionals, safety experts
Effective Period: 2024
Approval Date: January 12, 2024
Date of Changes: January 12, 2024
Low Dose Aspirin in Pregnancy
Year: 2023
Region / city: Canberra, Australia
Topic: Obstetrics, Pre-eclampsia, Pregnancy Care
Document type: Guideline
Organization / institution: Canberra Health Services
Author: Society of Obstetric Medicine Australia and New Zealand (SOMANZ)
Target audience: Medical Officers, Registered Nurses, Registered Midwives, Students, Pharmacists
Period of validity: Not specified
Approval date: 2023
Date of amendments: Not specified
Preparation of Aspirin: Pupil Guide
Title: Preparation of Aspirin
Document Type: Laboratory Guide
Subject: Chemistry
Topic: Synthesis of Aspirin
Chemical Reaction: Condensation of 2-hydroxybenzoic acid with ethanoic anhydride
Product: Aspirin (acetylsalicylic acid)
Educational Level: Pupil
Required Chemicals: 2-hydroxybenzoic acid; ethanoic anhydride; 85% phosphoric acid; ethanol; deionised water
Required Equipment: Conical flasks; measuring cylinders; beakers; thermometers; balance; hot plate; Buchner funnel and flask; water pump; oven; melting point apparatus
Safety Requirements: Use of eye protection (BS EN166 3); gloves; fume cupboard handling
Procedure Includes: Heating to 85°C; recrystallisation; filtration; drying; melting point determination
Analytical Methods: Determination of melting point; calculation of percentage yield
Aspirin and ticagrelor's versus aspirin and clopidogrel or pasugrel’s and the effect on staphylococcal infection: A real-world study
Year: 2026
Region / City: Liverpool, UK
Topic: Antiplatelet therapy, Staphylococcal infections, ACS
Document Type: Research Study
Organization / Institution: University of Liverpool, Liverpool University Hospital NHS Foundation Trust
Author: Hani Essa, Wern Yew Ding, Faraz Rana, Sizheng Steven Zhao, Matthew Anson, Philip Austin, Gema Hernández, Pankaj Lal, Gregory Y. H. Lip, Uazman Alam
Target Audience: Healthcare professionals, researchers in cardiovascular medicine, infectious disease specialists
Study Period: 5 years
Date Approved: 2026-03-06
Date Modified: 2026-03-06
Esterification (synthesis of aspirin)
Year: 1897
Region / city: Not specified
Topic: Chemistry, Esterification, Synthesis of Aspirin
Document type: Laboratory Experiment Procedure
Organization / Institution: Bayer (mentioned in context)
Author: Not specified
Target audience: Chemistry students, laboratory professionals
Period of validity: Not specified
Date of approval: Not specified
Date of changes: Not specified
Topics: ATACAS TraneXamic Aspirin